Yale Jen
Stock Analyst at Laidlaw & Co.
(0.27)
# 4,363
Out of 5,090 analysts
14
Total ratings
14.29%
Success rate
-11.07%
Average return
Main Sectors:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FEMY Femasys | Initiates: Buy | $6.5 | $0.88 | +638.64% | 1 | Nov 20, 2025 | |
| NSRX Nasus Pharma | Initiates: Buy | $22 | $6.53 | +237.16% | 1 | Sep 29, 2025 | |
| SNTI Senti Biosciences | Initiates: Buy | $5 | $2.13 | +134.74% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $51.37 | +104.40% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $6.71 | +183.16% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $10 | $0.73 | +1,269.11% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $114.51 | -58.08% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $475 | $5.17 | +9,087.62% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $225 | $1.79 | +12,469.83% | 1 | Mar 18, 2024 | |
| CING Cingulate | Downgrades: Hold | n/a | $3.99 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.44 | +2,178.94% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $3.61 | - | 1 | Aug 15, 2023 |
Femasys
Nov 20, 2025
Initiates: Buy
Price Target: $6.5
Current: $0.88
Upside: +638.64%
Nasus Pharma
Sep 29, 2025
Initiates: Buy
Price Target: $22
Current: $6.53
Upside: +237.16%
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $2.13
Upside: +134.74%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $51.37
Upside: +104.40%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $6.71
Upside: +183.16%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $0.73
Upside: +1,269.11%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $114.51
Upside: -58.08%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $475
Current: $5.17
Upside: +9,087.62%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $1.79
Upside: +12,469.83%
Cingulate
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.99
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.44
Upside: +2,178.94%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $3.61
Upside: -